NCT05202730

Brief Summary

Local anesthesia was performed on patients with total knee arthroplasty (TKA) through two different injection sites of local anesthetics and two local anesthetic drug . The pain score of patients after TKA was collected, then the analgesic effect of patients after TKA through two different injection sites and two different local anesthetic drug were analyzed and evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

December 25, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 21, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
Last Updated

March 6, 2023

Status Verified

March 1, 2023

Enrollment Period

1.6 years

First QC Date

December 5, 2021

Last Update Submit

March 3, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of the pain score before and after surgery

    A Visual Analogue Scale (VAS) is used to measure the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain. Using a ruler, the score is determined by measuring the distance (mm) on the 10cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

    pre-operation, 6hours after surgery, 24hours after surgery, 48 hours after surgery.

Study Arms (4)

Traditional injection site and traditional local anesthetic formulation

OTHER
Procedure: New local anesthesia injection site and new local anesthetic drug formulation.

Traditional injection site and new local anesthetic formulation

EXPERIMENTAL
Procedure: New local anesthesia injection site and new local anesthetic drug formulation.

New injection site and traditional local anesthetic formulation

EXPERIMENTAL
Procedure: New local anesthesia injection site and new local anesthetic drug formulation.

New injection site and new local anesthetic formulation

EXPERIMENTAL
Procedure: New local anesthesia injection site and new local anesthetic drug formulation.

Interventions

The traditional injection site is the posterior joint capsule and the popliteal artery space (iPACK) plus multiple layers of tissues around the knee joint (posterior joint capsule, ligaments and subcutaneous tissue). The traditional local anesthetic formulation is 1% ropivacaine 10ml+ normal saline 40ml+10mg Morphine + 5mg dexamethasone. The new local anesthesia injection site is iPACK+Knee Cutaneous Nerve Block. The new local anesthetic formula is 1% ropivacaine 10ml+ normal saline 40ml+10mg morphine+1ml triamcinolone acetonide.

New injection site and new local anesthetic formulationNew injection site and traditional local anesthetic formulationTraditional injection site and new local anesthetic formulationTraditional injection site and traditional local anesthetic formulation

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients between the ages of 40-75, who meet the indications for total knee arthroplasty(TKA) surgery, plan to undergo unilateral TKA surgery, can tolerate surgical trauma, and have no surgical contraindications;
  • \. Patients who have good medical obedience and can cooperate to complete the evaluation of various indicators after the operation and continue to receive follow-up;
  • \. There is no contraindications to combined spinal-epidural anesthesia;
  • \. Agree to accept this trial and sign an informed consent form.

You may not qualify if:

  • \. Allergic to test drugs;
  • \. Abnormal liver, kidney or heart function;
  • \. People who have chronic pain symptoms in other parts of the body other than the knee joint;
  • \. Patients with a history of multiple operations on the knee joint, or patients with abnormal anatomical structures;
  • \. Patients who cannot perform early functional exercise after unconventional knee replacement or other systemic diseases;
  • \. Cannot communicate with researchers normally.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedics, Xijing Hospital, The Air Force Medical University

Xi’an, Shanxi, 710032, China

RECRUITING

Related Publications (1)

  • Diwu W, Tang W, Yan M, Ma W, Xu H, Sun Q, Han Y, Wang Y, Wang C, Zhang D, Bi L, Yang M. Efficacy of Peripheral Cutaneous Nerve (PCN) on postoperative pain and functional outcome after total knee arthroplasty: a single-blind, randomized controlled clinical trial". BMC Anesthesiol. 2025 Jul 1;25(1):322. doi: 10.1186/s12871-025-03182-z.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Weilong Diwu, M.M.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 5, 2021

First Posted

January 21, 2022

Study Start

December 25, 2021

Primary Completion

July 31, 2023

Study Completion

December 10, 2023

Last Updated

March 6, 2023

Record last verified: 2023-03

Locations